A PRX4-overexpressed transgenic mouse model revealed that reduced oxidative stress through overexpressed PRX4 promotes cancer development, such as with highly penetrated microvessels in tumors; upregulated cytokine levels, including IL-1β and matrix metallopeptidase 9; and enhanced tumor size [74]. The gene discussed is PRDX4; the disease is neoplasm.